Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

1,500 patients to fuel pancreatic cancer research

NCT ID NCT06128343

Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects tumor tissue and medical information from 1,500 people with pancreatic cancer. The goal is to build a large biobank that scientists can use to better understand the disease and develop new treatments. Participants undergo standard diagnostic procedures, and no experimental therapy is offered.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2023

Expected to finish

Feb 2035

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with a pancreatic adenocarcinoma proven cytologically or histologically without any treatment

Ages

18 to 120 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture or * Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route or * Patient with pancreatic adenocarcinoma proven histologically and/or cytologically Exclusion Criteria: * Patient with a pancreatic tumor whose analysis histological is not an adenocarcinoma * Pregnant or breastfeeding patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

adenocarcinoma carcinoma neoplasm pancreatic adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adenocarcinoma Carcinoma Neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Béthune hospital center

    NOT_YET_RECRUITING

    Béthune, 62408, France

  • Haut-Lévêque Hospital

    NOT_YET_RECRUITING

    Bordeaux, 33604, France

  • Huriez Hospital

    NOT_YET_RECRUITING

    Lille, 59037, France

  • Jean Mermoz private hosptila

    NOT_YET_RECRUITING

    Lyon, 69008, France

  • PAU hospital

    NOT_YET_RECRUITING

    Pau, 6400, France

  • Rangueil hospital

    RECRUITING

    Toulouse, 31059, France

  • Regional Cancer Center From Montpellier

    NOT_YET_RECRUITING

    Montpellier, 34298, France

  • Saint Eloi Hospital

    NOT_YET_RECRUITING

    Montpellier, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.